Oridonin Sensitizes Hepatocellular Carcinoma to the Anticancer Effect of Sorafenib by Targeting the Akt Pathway

Oridonin Sensitizes Hepatocellular Carcinoma to the Anticancer Effect of Sorafenib by Targeting the Akt Pathway

Xuguang Li,1,2 Weirun Chen,2 Kaihang Liu,3 Sheng Zhang,2 Ru Yang,4 Kairui Liu,2 Dateng Li,5 Youxing Huang2 1Department of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong Province, People’s Republic of China; 2Department of Abdominal Surgery, The Sec...

Full description

Bibliographic Details
Main Authors: Li X, Chen W, Liu K, Zhang S, Yang R, Li D, Huang Y
Format: Article
Language:English
Published: Dove Medical Press 2020-09-01
Series:Cancer Management and Research
Subjects:
oridonin
sorafenib
hcc
akt pathway
Online Access:https://www.dovepress.com/oridonin-sensitizes-hepatocellular-carcinoma-to-the-anticancer-effect--peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/oridonin-sensitizes-hepatocellular-carcinoma-to-the-anticancer-effect--peer-reviewed-article-CMAR

Similar Items